SHS Gesellschaft für Beteiligungsmanagement mbH
4. February 2021 - Newsletter

SHS invests in innovative specialist for drugs formulated specifically for delayed-release effects

Develco Pharma, a Swiss-German firm, has been developing and producing orally administered, delayed-release drugs with special formulations since 2006. Since 2016, the company has produced these drugs in a state-of-the-art production facility located in Schopfheim, in the Baden region of Germany. The dynamic, medium-sized company is gradually growing its pipeline for new drugs, and there are new therapeutic areas on its agenda. Develco Pharma’s customers include globally leading pharmaceutical companies. Through its investment, SHS is supporting the strong course of growth at Develco Pharma.

Read more about this in the latest press release: